文献速递认知障碍与痴呆脑血管病

主动脉僵硬与神经炎症、突触功能障碍及神经退行性生物标志物的关联

Association of Aortic Stiffness With Biomarkers of Neuroinflammation, Synaptic Dysfunction, and Neurodegeneration.
PubMed 文献 · Neurology · 2021-05-24

结果显示,在年龄>73岁的参与者中,较高的主动脉PWV与较高的p-tau、t-tau、神经颗粒素及YKL-40浓度相关,提示主动脉僵硬与神经炎症、tau磷酸化、突触功能障碍及神经退行性变相关,但与淀粉样变无关。

要点

  • 在>73岁老年人中,主动脉PWV升高与脑脊液p-tau、t-tau、神经颗粒素及YKL-40升高相关。
  • 主动脉PWV与年龄存在交互作用,影响p-tau、t-tau、神经颗粒素和sTREM2。
  • 主动脉僵硬未显示与脑脊液Aβ标志物相关。

核心结论

  • 在≥74岁参与者中,较高的主动脉僵硬与神经炎症、tau磷酸化、突触功能障碍和神经退行性变的体内生物标志物证据相关,但与淀粉样变无关。
  • 中枢动脉僵硬可能导致累积性脑微循环损伤和血流输送减少,从而在更晚期年龄导致神经炎症和神经退行性变。

研究设计与样本

  • 观察性社区队列研究(Vanderbilt记忆与衰老项目),纳入无卒中及痴呆的老年人。
  • 采用线性回归分析主动脉PWV与脑脊液Aβ、p-tau、t-tau、神经颗粒素、NFL、YKL-40及sTREM2浓度的关系,并调整年龄、种族/民族、教育、APOE ε4状态、Framingham卒中风险概况及认知诊断。

主要发现

  • 主动脉PWV与年龄在p-tau(β=0.31,p=0.04)、t-tau(β=2.67,p=0.05)、神经颗粒素(β=0.94,p=0.04)和sTREM2(β=20.4,p=0.05)上存在交互作用。
  • 在>73岁参与者中,较高的主动脉PWV与较高的p-tau(β=2.4,p=0.03)、t-tau(β=19.3,p=0.05)、神经颗粒素(β=8.4,p=0.01)及YKL-40浓度(β=7,880,p=0.005)相关。
  • 主动脉PWV与诊断在神经颗粒素上存在 modest 交互作用(β=-10.76,p=0.03),与高血压状态在YKL-40上存在交互作用(β=18,020,p<0.001)。

临床怎么用

  • 在老年人群中,评估主动脉僵硬可能有助于识别神经炎症和神经退行性变风险较高的个体。
  • 针对主动脉僵硬的干预措施可能有助于延缓脑微循环损伤及相关神经退行性变,尤其在高龄人群中。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To test the hypothesis that increased aortic stiffening is associated with greater CSF evidence of core Alzheimer disease pathology (β-amyloid [Aβ], phosphorylated tau [p-tau]), neurodegeneration (total tau [t-tau]), synaptic dysfunction (neurogranin), neuroaxonal injury (neurofilament light [NFL]), and neuroinflammation (YKL-40, soluble triggering receptor expressed on myeloid cells 2 [sTREM2]), we analyzed pulse wave velocity (PWV) data and CSF data among older adults. METHODS: Participants free of stroke and dementia from the Vanderbilt Memory and Aging Project, an observational community-based study, underwent cardiac magnetic resonance to assess aortic PWV (meters per second) and lumbar puncture to obtain CSF. Linear regressions related aortic PWV to CSF Aβ, p-tau, t-tau, neurogranin, NFL, YKL-40, and sTREM2 concentrations after adjustment for age, race/ethnicity, education, apolipoprotein (APOE) ε4 status, Framingham Stroke Risk Profile, and cognitive diagnosis. Models were repeated testing PWV interactions with age, diagnosis, APOE ε4, and hypertension on each biomarker. RESULTS: One hundred forty-six participants were examined (age 72 ± 6 years). Aortic PWV interacted with age on p-tau (β = 0.31, p = 0.04), t-tau, (β = 2.67, p = 0.05), neurogranin (β = 0.94, p = 0.04), and sTREM2 (β = 20.4, p = 0.05). Among participants >73 years of age, higher aortic PWV related to higher p-tau (β = 2.4, p = 0.03), t-tau (β = 19.3, p = 0.05), neurogranin (β = 8.4, p = 0.01), and YKL-40 concentrations (β = 7,880, p = 0.005). Aortic PWV had modest interactions with diagnosis on neurogranin (β = -10.76, p = 0.03) and hypertension status on YKL-40 (β = 18,020, p < 0.001). CONCLUSIONS: Among our oldest participants, ≥74 years of age, greater aortic stiffening is associated with in vivo biomarker evidence of neuroinflammation, tau phosphorylation, synaptic dysfunction, and neurodegeneration, but not amyloidosis. Central arterial stiffening may lead to cumulative cerebral microcirculatory damage and reduced blood flow delivery to tissue, resulting in neuroinflammation and neurodegeneration in more advanced age.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Moore EE, Liu D, Li J, et al. Association of Aortic Stiffness With Biomarkers of Neuroinflammation, Synaptic Dysfunction, and Neurodegeneration. Neurology. 2021. PMID: 34031194. doi:10.1212/WNL.0000000000012257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。